ZymoGenetics gets OK for blood-clotting drug size

Recs

0

ZymoGenetics Inc. said Tuesday the Food and Drug Administration approved a larger vial size for the biotechnology company's blood-clotting drug Recothrom Thrombin.

The drug was already available in 5,000 IU vials and is approved in 20,000 IU vials. International Units, or IUs, is a measurement used for drugs.

The company also received approval for a spray kit with the blood-clotting drug.

Shares of ZymoGenetics rose 20 cents, or 2.3 percent, to $9.10 in morning trading. The stock has traded between $8.09 and $16.80 over the last 52 weeks.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 652312, ~/articles/articlehandler.aspx, 12/1/2008 10:31:33 AM,

Sign up for FREE Motley Fool site access to keep reading:

“ZymoGenetics gets OK for blood-clotting drug size”

Signing up allows you to comment on articles and on the discussion boards.

It's completely FREE and will take only 10 seconds.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recommended

Market Summary

S&P 500855.28 -4.57%
DJIA8,489.90 -3.84%
NASD1,468.97 -4.34%
Updated: 10:16:01 AM
Sponsored by:

Related Tickers

ZymoGenetics, Inc.

CAPS Rating 2/5 Stars

$2.56

-0.15 (-5.54%)

Outperform104

Underperform26

Rate This Stock